Barriers Limiting OCT Penetration in Clinical Practice

Not yet recruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

December 15, 2025

Study Completion Date

May 15, 2026

Conditions

Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))

All Listed Sponsors

lead

Consorzio Futuro in Ricerca

OTHER

NCT07193693 - Barriers Limiting OCT Penetration in Clinical Practice | Biotech Hunter | Biotech Hunter